Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) | MicrobiomeTrials← Back to trialsNCT04317794
Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)
RecruitingOBSERVATIONAL
Trial Details
Start: 2019-07-02Est. Completion: 2027-02-05
Enrollment target: 74 participants Locations- Pusan Natioanl University Hospital, Busan, South Korea
- Samsung Changwon Hospital, Changwon, South Korea
- Chungbuk National University Hospital, Cheongju-si, South Korea
- Kyungpook National University Hospital, Daegu, South Korea
- Yeungnam University Hospital, Daegu, South Korea
- Chungnam National University Hospital, Daejeon, South Korea
- Chonnam National University Hospital, Gwangju, South Korea
- Chonbuk National University Hospital, Jeonju, South Korea
- Severance Hospital, Seoul, South Korea
- Asan Medical Center, Seoul, South Korea
- Korea university Anam Hospital, Seoul, South Korea
- Korea University Guro Hospital, Seoul, South Korea
- Samsung Medical Center, Seoul, South Korea
- Seoul Natioanl University Hospital, Seoul, South Korea
- Severance Hospital, Yonsei University Health System, Seoul, South Korea
- Pusan National University Yangsan Hospital, Yangsan, South Korea
Other microbiome trials you might be interested in
Spinal Muscular Atrophy
This prospective interventional study evaluates the immediate and sustained effects of intensive equine-assisted physiot…
Prague, CzechiaCompleted Sep 25, 2024
Spinal Cord InjuryAmyotrophic Lateral SclerosisBrain Stem InfarctionsLocked-in SyndromeMuscular Dystrophy
VA research has been advancing a high-performance brain-computer interface (BCI) to improve independence for Veterans an…
Providence, United StatesEst. completion Jun 30, 2027